Is durvalumab (durvalumab) included in medical insurance? What is the medical insurance reimbursement rate?

Durvalumab (Durvalumab) is currently on the market in China, but has not yet been included in medical insurance. Since this drug has not yet been included in medical insurance, patients need to bear the cost of the drug themselves when purchasing it. The common specifications of durvalumab in the domestic market are 120mg/2.4mL and 500mg/10mL. The price of each box is usually between more than 4,000 yuan to more than 10,000 yuan. The specific price will fluctuate depending on the drug specifications, pharmacies and regions.

Since durvalumab has not yet been included in medical insurance, patients need to pay the full cost of the drug when purchasing it, and the cost is relatively high. This may pose a greater burden to some patients with limited financial resources. However, with the gradual popularization of drug use and the in-depth clinical research, it is possible that corresponding policy adjustments will be made in the future to gradually include such drugs in the scope of medical insurance, thereby alleviating the financial pressure on patients.

Currently, there are no generic drugs of durvalumab on the domestic market, resulting in a relatively high price. The original drug of durvalumab is already available overseas, with specifications and dosages similar to those in China. The common specifications are 120mg/2.4mL. Each box may be sold for more than a thousand US dollars, and the price is also affected by exchange rate fluctuations. Although overseas prices are relatively high, patients still face higher treatment costs compared with domestic selling prices.

With future changes in medical insurance policies, durvalumab may be included in the scope of medical insurance, thereby providing a certain reimbursement ratio. This can reduce the patient's medication burden and enable more patients to benefit from this treatment. During the current treatment process, patients need to fully communicate with their doctors to understand the treatment options and cost issues, and choose a suitable payment method if conditions permit.

Reference materials:https://www.imfinzi.com/